MoneyWorks4Me

USFDA completes GMP inspection at Dr. Reddy's API Middleburgh facility in New York

17 May 2025 Evaluate

United States Food & Drug Administration (USFDA) has completed a GMP inspection at Dr. Reddy’s Laboratories’ API Middleburgh facility in New York. The inspection was conducted from May 12, 2025 to May 16, 2025. The company has been issued a Form 483 with two observations, which it will address within the stipulated timeline.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.

Dr. Reddys Labs. Share Price

1181.75 -12.75 (-1.07%)
25-Aug-2026 13:52 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1903.95
Dr. Reddys Labs. 1181.75
Cipla 1417.65
Lupin 2173.65
Zydus Lifesciences 1110.20
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: